In the Clinic Prevention and Initial Management of HIV Infection

被引：7

作者：

Feinberg, Judith ^{[1
]}

Keeshin, Susana

机构：

[1] West Virginia Univ, Sch Med, Morgantown, WV 26506 USA

来源：

ANNALS OF INTERNAL MEDICINE | 2022年 / 175卷 / 06期

关键词：

HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; PREEXPOSURE PROPHYLAXIS; HUMAN-PAPILLOMAVIRUS; VIRAL LOAD; PERFORMANCE; RECOMMENDATIONS; TRANSMISSION; MORTALITY; SAFETY;

D O I：

10.7326/AITC202206210

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Since July 2017, when In the Clinic last addressed management of HIV infection, there have been meaningful improvements in our ability to prevent HIV and to manage patients living with HIV. New approaches to preexposure prophylaxis and more effective treatments have made the elimination of HIV infection a feasible goal. The federal “Ending the HIV Epidemic” initiative aims at a 90% reduction in new HIV diagnoses by 2030. This article provides updated information on how clinicians should use these improvements to manage their patients who are at risk for HIV infection or are newly diagnosed with HIV. © 2022 American College of Physicians

引用

页码：ITC81 / ITC95

页数：15

共 36 条

[1]

[Anonymous], 2016, MMWR Morb Mortal Wkly Rep, V65, P458, DOI 10.15585/mmwr.mm6517a5

[2]

[Anonymous], 2018, HIV SURV REP, V30

[3]

[Anonymous], 2016, NEW ENGL J MED

[4]

[Anonymous], 2021, HIV Surveillance Supplemental Report, P26

[5]

Association of Public Health Laboratories, 2019, SUGG REP LANG HIV LA

[6] Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women [J].

Baeten, J. M. ;

Palanee-Phillips, T. ;

Brown, E. R. ;

Schwartz, K. ;

Soto-Torres, L. E. ;

Govender, V. ;

Mgodi, N. M. ;

Kiweewa, F. Matovu ;

Nair, G. ;

Mhlanga, F. ;

Siva, S. ;

Bekker, L. -G. ;

Jeenarain, N. ;

Gaffoor, Z. ;

Martinson, F. ;

Makanani, B. ;

Pather, A. ;

Naidoo, L. ;

Husnik, M. ;

Richardson, B. A. ;

Parikh, U. M. ;

Mellors, J. W. ;

Marzinke, M. A. ;

Hendrix, C. W. ;

van der Straten, A. ;

Ramjee, G. ;

Chirenje, Z. M. ;

Nakabiito, C. ;

Taha, T. E. ;

Jones, J. ;

Mayo, A. ;

Scheckter, R. ;

Berthiaume, J. ;

Livant, E. ;

Jacobson, C. ;

Ndase, P. ;

White, R. ;

Patterson, K. ;

Germuga, D. ;

Galaska, B. ;

Bunge, K. ;

Singh, D. ;

Szydlo, D. W. ;

Montgomery, E. T. ;

Mensch, B. S. ;

Torjesen, K. ;

Grossman, C. I. ;

Chakhtoura, N. ;

Nel, A. ;

Rosenberg, Z. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (22) :2121-2132

[7]

Branson B., LAB TEST DIAGN HIV I, DOI DOI 10.15620/CDC.23447

[8]

Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1

[9]

Centers for Disease Control and Prevention, Core Indicators for Monitoring the Ending the HIV Epidemic Initiative (Preliminary Data): National HIV Surveillance System Data Reported Through September 2021

[10]

and Preexposure Prophylaxis (PrEP) Data Reported Through June 2021

← 1 2 3 4 →